Jobs
>
San Francisco

    Accounting Operations, Senior Manager 89bio - San Francisco, United States - snaphire

    snaphire
    snaphire San Francisco, United States

    3 days ago

    Default job background
    Description


    89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases.

    The company's lead product candidate, pegozafermin (BIO89-100), is a specifically engineered glycoPEGylated analog of FGF21. Pegozafermin is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG).

    THE ROLE
    Reporting initially to the Senior Director of Global Finance and over the longer term to the Associate Director of Accounting the

    Accounting Operations, Senior Manager

    will be responsible for all aspects of operations and processes in compliance with financial policies and procedures.

    THE RESPONSIBILITIES
    Responsible for month end, Quarter end and year end closing procedures as required.

    Perform close related activities, including assigned reconciliations, research transactions, assist with Clinical Trial, CMC and other R&D and G&A accruals etc.

    Assist the Associate Director in overseeing the AP function, ensuring that PO's are in place, investigate exceptions, maintain dashboards etc.

    Responsible for adherence to the SOX controls for AP, Accruals and assisting in other areas. Will also, over time, be expected to enhance existing controls as appropriate.
    Work closely with the Director of FP&A to ensure appropriate coding of invoices and investigating any exceptions.
    Assist in reviewing and resolving payment blocks placed on vendors and/or specific invoices.
    Update procedures for business processes as needed.
    Advanced familiarity with Coupa and NetSuite.

    Assist with ad hoc assignments, project work, testing of new processes and procedures within ERP and other Systems as needed.


    THE QUALIFICATIONS
    10 plus years of related accounting experience.
    Industry experience highly desired.
    In depth knowledge of general ledger posting process.
    Excellent interpersonal skills/ highly collaborative, team player and ability to cultivate strong internal/external network of relationships.
    The ability to anticipate and remediate problems that arise is essential.
    Very proactive, detail-oriented, organized and diligently follow-up on all issues until they are resolved satisfactorily.
    Committed to highest levels of professional excellence.
    Strong analytical problem-solving & interpersonal skills.
    Experience with working in high growth, collaborative organizations.
    Team oriented, highly motivated, execution focused with strong work ethic, ability to thrive in a high growth, entrepreneurial environment.
    Highly adaptable and responsive to technical and business opportunities and needs - Comfortable delivering against challenging commitments.
    SALARY & LEVEL
    89bio considers a range of factors when determining the salary and level. These considerations mean actual salary and level may vary. The salary range for this position is $180,000 - $190,000 and will be commensurate with experience.

    THE PERKS
    Competitive health insurance coverage
    Employee Stock Purchase Plan (ESPP)
    Women's forum / mentoring
    Office based in the heart of San Francisco, near plenty of shops and restaurants
    Fun opportunities to engage with co-workers in-person and remotely

    All qualified applicants will receive consideration for employment without regard to race, sex, color, religion, sexual orientation, gender identity, national origin, protected veteran status, or based on disability.

    Proof of Covid vaccination is a condition of employment.

    Notice to Recruiters:


    To protect the interest of all parties, 89bio does not accept unsolicited resumes and we ask that employees, hiring managers and executives not be contacted directly.

    All recruitment is managed through the 89bio Talent Acquisition Team.

    #J-18808-Ljbffr


  • 89bio, Inc. San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically e ...


  • 89bio, Inc. San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically e ...


  • snaphire San Francisco, United States

    GCP Clinical Quality Assurance, Senior Director · LINKEDINMEDIACODE: · THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company ...


  • 89bio, Inc. San Francisco, CA, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...


  • 89bio San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically e ...


  • 89bio, Inc. San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically e ...


  • 89bio San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...


  • 89bio, Inc. San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically e ...


  • 89bio San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...


  • 89bio, Inc. San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically e ...

  • 89bio, Inc.

    Executive Assistant

    6 days ago


    89bio, Inc. San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically e ...


  • 89bio San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...


  • 89bio San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...


  • 89bio, Inc. San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically e ...


  • 89bio San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...


  • snaphire San Francisco, CA, United States

    Clinical Business Operations, Associate Director/Director · THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead pr ...

  • snaphire

    Head of Operations

    1 week ago


    snaphire San Francisco, CA, United States

    89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically engineered glyc ...


  • snaphire San Francisco, CA, United States

    89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically engineered glyc ...


  • snaphire San Francisco, United States

    89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically engineered glyc ...

  • 89bio

    CMC Operations

    2 days ago


    89bio San Francisco, United States

    THE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...